This content is from: Canada

Proposed regulations to adjust generic balance

The Canadian government has proposed changes to the regulations governing patented medicines and data exclusivity. David Heller and Adrian Zahl of Ridout & Maybee explain how the reforms will affect the research-based and generic industries

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial